Clinical Trials Sponsored by Vistakon

Total 26 results

Vistakon Pharmaceuticals

Completed

Safety and Efficacy of a Drug Delivery System in Glaucoma

Ocular Hypertension | Open-angle Glaucoma

United States
Vistakon Pharmaceuticals

Completed

A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs

Ocular Hypertension | Open-angle Glaucoma

United States
Vistakon Pharmaceuticals

Completed

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open Angle

United States
Vistakon Pharmaceuticals

Completed

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Safety and Efficacy of a Glaucoma Drug Delivery System

Ocular Hypertension | Glaucoma, Open-Angle

United States
Vistakon Pharmaceuticals

Completed

Safety Study of a Contact Lens With Ketotifen in Healthy, Normal Volunteers

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Safety and Efficacy Study of a Eye Drop for Eye Allergy

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Vistakon Pharmaceuticals

Completed

Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Santen Inc.
Vistakon Pharmaceuticals

Terminated

Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery

Corneal Transplantation

United States
Santen Inc.
Vistakon Pharmaceuticals

Completed

Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator

Cataract

United States
VistaGen Therapeutics, Inc.

Recruiting

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) (PALISADE-3)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Terminated

Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Completed

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge (Palisade-1)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.

Completed

AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression (ELEVATE)

Major Depressive Disorder

United States
VistaGen Therapeutics, Inc.

Not yet recruiting

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Parkinson Disease | Dyskinesia, Medication-Induced | L-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc.

Completed

PH94B in the Treatment of Adjustment Disorder With Anxiety

Adjustment Disorder With Anxious Mood

United States
VistaGen Therapeutics, Inc.

Terminated

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2 (Palisade-2)

Social Anxiety Disorder

United States
VistaGen Therapeutics, Inc.
Parexel

Recruiting

AV-101 Alone and in Combination With Probenecid in Healthy Subjects

Drug Drug Interaction

United States
VistaGen Therapeutics, Inc.
National Institute on Drug Abuse (NIDA); Cato Research

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of AV-101 in Healthy Volunteers

Neuropathic Pain

United States
The Hospital of Vestfold
Vitacon AS, Vegamot 8, 7048 Trondheim, Norway

Completed

Treatment of Dysmenorrhoea With the OVA TENS Apparatus

Dysmenorrhoea

Norway
Marijn Lijffijt, PhD
Michael E. DeBakey VA Medical Center; VistaGen Therapeutics, Inc.

Completed

Electrophysiological Biomarkers of AV-101

Healthy

United States

Clinical Trials Sponsored by Vistakon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations